Which has grown faster, NRC or OVID?

Neither grew: over the past five years both shrank revenue, with NRC's decline the smaller — NRC at a -0.02% CAGR versus OVID at -62.76%.

Does NRC or OVID pay a bigger dividend?

NRC pays a dividend (2.89% yield), while OVID has no payments in the available dividend history.

Is NRC or OVID more profitable?

NRC runs the higher net margin — NRC at 4.18% versus OVID at -2178.90%.

How have NRC and OVID total returns compared?

Over the past 5 years, NRC delivered -11.49% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.

NRC Health (NRC) vs Ovid Therapeutics Inc. (OVID)

A side-by-side comparison of NRC Health and Ovid Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NRC

NRC Health

$459M

$20.38HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

OVID

Ovid Therapeutics Inc.

$446M

$2.39HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

Total return — NRC vs OVID

growth of $100 · dividends reinvested · last 9y

NRC -0.3% (-0.0%/yr)OVID -80.9% (-16.8%/yr)NRC compounded faster over this window

Log scale — wide-divergence pair

NRC OVID

NRC vs OVID: by the numbers

•NRC is the larger company ($459M vs $446M market cap).
•NRC is profitable (4.18% net margin) while OVID runs a net loss (-2178.90%).
•Both shrank revenue over the past five years; NRC's decline was smaller (-0.02% vs -62.76% CAGR).
•NRC pays a dividend (2.89% yield), while OVID has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	NRC	OVID
P/E ratio	80.76	N/A
Forward P/E	23.16	N/A
P/S ratio	3.28	281.81
P/B ratio	70.15	2.13
EV / EBITDA	23.37	N/A
FCF yield	4.71%	N/A

Profitability

Metric	NRC	OVID
Gross margin	56.33%	100.00%
Operating margin	10.53%	-585.20%
Net margin	4.18%	-2178.90%
ROE	89.43%	-16.43%
ROIC	8.75%	-26.29%

Dividends

Metric	NRC	OVID
Dividend yield	2.89%	N/A
Payout ratio	237.72%	N/A

Growth (annualized)

Metric	NRC	OVID
Revenue CAGR (5Y)	-0.02%	-62.76%
EPS CAGR (5Y)	-18.88%	N/A
FCF CAGR (5Y)	-14.35%	N/A
Total return CAGR (5Y)	-11.49%	-6.98%

Frequently asked

Which has grown faster, NRC or OVID?: Neither grew: over the past five years both shrank revenue, with NRC's decline the smaller — NRC at a -0.02% CAGR versus OVID at -62.76%.
Does NRC or OVID pay a bigger dividend?: NRC pays a dividend (2.89% yield), while OVID has no payments in the available dividend history.
Is NRC or OVID more profitable?: NRC runs the higher net margin — NRC at 4.18% versus OVID at -2178.90%.
How have NRC and OVID total returns compared?: Over the past 5 years, NRC delivered -11.49% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full NRC analysis Full OVID analysis Interactive comparison tool

Dig into the metrics

NRC Health P/E ratio NRC Health dividend yield NRC Health ROE Ovid Therapeutics ROE NRC Health operating margin Ovid Therapeutics operating margin NRC Health revenue growth Ovid Therapeutics revenue growth NRC Health free cash flow Ovid Therapeutics free cash flow

NRC Health & Ovid Therapeutics appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.